Elisabetta Botti

2.3k total citations · 1 hit paper
35 papers, 1.6k citations indexed

About

Elisabetta Botti is a scholar working on Immunology, Dermatology and Molecular Biology. According to data from OpenAlex, Elisabetta Botti has authored 35 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Immunology, 20 papers in Dermatology and 7 papers in Molecular Biology. Recurrent topics in Elisabetta Botti's work include Psoriasis: Treatment and Pathogenesis (19 papers), Dermatology and Skin Diseases (12 papers) and T-cell and B-cell Immunology (6 papers). Elisabetta Botti is often cited by papers focused on Psoriasis: Treatment and Pathogenesis (19 papers), Dermatology and Skin Diseases (12 papers) and T-cell and B-cell Immunology (6 papers). Elisabetta Botti collaborates with scholars based in Italy, United States and Romania. Elisabetta Botti's co-authors include Antonio Costanzo, Sergio Chimenti, Barbara Marinari, Giulia Spallone, Giovanni Monteleone, Francesca Moretti, Roberta Caruso, Luis M. Vence, Camilla Jandus and Susan Y. Chon and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Nature Medicine.

In The Last Decade

Elisabetta Botti

35 papers receiving 1.5k citations

Hit Papers

The antimicrobial peptide LL37 is a T-cell autoantigen in... 2014 2026 2018 2022 2014 100 200 300 400

Peers

Elisabetta Botti
Ge Shi China
Allen N. Sapadin United States
Bernhard Ortel United States
Travis Vandergriff United States
Mohamed Kamal United States
Elisabetta Botti
Citations per year, relative to Elisabetta Botti Elisabetta Botti (= 1×) peers Maki Ozawa

Countries citing papers authored by Elisabetta Botti

Since Specialization
Citations

This map shows the geographic impact of Elisabetta Botti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elisabetta Botti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elisabetta Botti more than expected).

Fields of papers citing papers by Elisabetta Botti

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elisabetta Botti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elisabetta Botti. The network helps show where Elisabetta Botti may publish in the future.

Co-authorship network of co-authors of Elisabetta Botti

This figure shows the co-authorship network connecting the top 25 collaborators of Elisabetta Botti. A scholar is included among the top collaborators of Elisabetta Botti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elisabetta Botti. Elisabetta Botti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Moltrasio, Chiara, Elisabetta Botti, Damiano Abeni, et al.. (2023). Clinical Features and Response to Treatment in Elderly Subjects Affected by Hidradenitis Suppurativa: A Cohort Study. Journal of Clinical Medicine. 12(24). 7754–7754. 2 indexed citations
2.
Caposiena, Raffaele Dante, Maria Vittoria Cannizzaro, Cosimo Di Raimondo, et al.. (2021). Long-term efficacy and safety of adalimumab on a severe case of hidradenitis suppurativa. Italian Journal of Dermatology and Venereology. 156(1). 2 indexed citations
3.
Mazzilli, Sara, Annunziata Dattola, Terenzio Cosio, et al.. (2021). Usefulness of Topical Imiquimod 3.75% in Cytokeratin 7 Positive Extramammary Paget Disease of the Vulva: Towards Personalized Therapy. Dermatology Practical & Conceptual. 11(2). e2021011–e2021011. 4 indexed citations
4.
Fratoddi, Ilaria, Luisa Benassi, Elisabetta Botti, et al.. (2019). Effects of topical methotrexate loaded gold nanoparticle in cutaneous inflammatory mouse model. Nanomedicine Nanotechnology Biology and Medicine. 17. 276–286. 51 indexed citations
5.
Chimenti, Maria Sole, Flavia Sunzini, Laura Fiorucci, et al.. (2018). Potential Role of Cytochrome c and Tryptase in Psoriasis and Psoriatic Arthritis Pathogenesis: Focus on Resistance to Apoptosis and Oxidative Stress. Frontiers in Immunology. 9. 2363–2363. 61 indexed citations
6.
Caposiena, Raffaele Dante, Maria Vittoria Cannizzaro, Elisabetta Botti, et al.. (2018). Clindamycin versus clindamycin plus rifampicin in hidradenitis suppurativa treatment: Clinical and ultrasound observations. Journal of the American Academy of Dermatology. 80(5). 1314–1321. 49 indexed citations
7.
Venditti, Iole, Luisa Benassi, Cristina Vaschieri, et al.. (2016). Functionalized gold nanoparticles for topical delivery of methotrexate for the possible treatment of psoriasis. Colloids and Surfaces B Biointerfaces. 141. 141–147. 119 indexed citations
8.
Galluzzo, Marco, Andreea Boca, Elisabetta Botti, et al.. (2015). IL12B (p40) Gene Polymorphisms Contribute to Ustekinumab Response Prediction in Psoriasis. Dermatology. 232(2). 230–236. 40 indexed citations
9.
Campione, Elena, Laura Diluvio, Alessandro Terrinoni, et al.. (2014). Severe erytrodermic psoriasis in child twins: from clinical-pathological diagnosis to treatment of choice through genetic analyses: two case reports. BMC Research Notes. 7(1). 929–929. 14 indexed citations
10.
Costanzo, Antonio, Natalia Pediconi, Alessandra Narcisi, et al.. (2014). TP63 and TP73 in cancer, an unresolved “family” puzzle of complexity, redundancy and hierarchy. FEBS Letters. 588(16). 2590–2599. 33 indexed citations
11.
Lande, Roberto, Elisabetta Botti, Camilla Jandus, et al.. (2014). The antimicrobial peptide LL37 is a T-cell autoantigen in psoriasis. Nature Communications. 5(1). 5621–5621. 416 indexed citations breakdown →
12.
Boca, Andreea, Marina Talamonti, Marco Galluzzo, et al.. (2013). Genetic variations in IL6 and IL12B decreasing the risk for psoriasis. Immunology Letters. 156(1-2). 127–131. 20 indexed citations
13.
Botti, Elisabetta, Giulia Spallone, Roberta Caruso, et al.. (2012). Psoriasis, from Pathogenesis to Therapeutic Strategies: IL-21 as a Novel Potential Therapeutic Target. Current Pharmaceutical Biotechnology. 13(10). 1861–1867. 24 indexed citations
14.
Hundhausen, Christian, Anna Bertoni, Rose Mak, et al.. (2011). Allele-Specific Cytokine Responses at the HLA-C Locus: Implications for Psoriasis. Journal of Investigative Dermatology. 132(3). 635–641. 22 indexed citations
15.
Sarra, Massimiliano, Roberta Caruso, Maria Laura Cupi, et al.. (2011). IL-21 Promotes Skin Recruitment of CD4+ Cells and Drives IFN-γ–Dependent Epidermal Hyperplasia. The Journal of Immunology. 186(9). 5435–5442. 35 indexed citations
16.
Costanzo, Antonio, Maria Sole Chimenti, Elisabetta Botti, et al.. (2010). IL-21 in the pathogenesis and treatment of skin diseases. Journal of Dermatological Science. 60(2). 61–66. 35 indexed citations
17.
Moretti, Francesca, Barbara Marinari, Nadia Lo Iacono, et al.. (2010). A regulatory feedback loop involving p63 and IRF6 links the pathogenesis of 2 genetically different human ectodermal dysplasias. Journal of Clinical Investigation. 120(5). 1570–1577. 112 indexed citations
18.
Caruso, Roberta, Elisabetta Botti, Massimiliano Sarra, et al.. (2009). Involvement of interleukin-21 in the epidermal hyperplasia of psoriasis. Nature Medicine. 15(9). 1013–1015. 166 indexed citations
19.
Marinari, Barbara, Francesca Moretti, Elisabetta Botti, et al.. (2008). The tumor suppressor activity of IKKα in stratified epithelia is exerted in part via the TGF-β antiproliferative pathway. Proceedings of the National Academy of Sciences. 105(44). 17091–17096. 55 indexed citations
20.
Costanzo, Antonio, Marina Talamonti, Giulia Spallone, et al.. (2008). Efficacy of Short-Term Cyclosporine Treatment to Control Psoriasis-Related Events during Efalizumab Therapy. Dermatology. 218(2). 146–150. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026